Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference values

Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference values

William Dunlop,1 Itrat Iqbal,1 Ifty Khan,2 Mario Ouwens,3 Louise Heron4 1Mundipharma International Limited, Cambridge, 2University College London, London, United Kingdom; 3Mapi HEOR, Houten, The Netherlands; 4Adelphi Values, Macclesfield, Cheshire, United Kingdom Background: Assessing the cost-effec...

Full description

Bibliographic Details
Main Authors: Dunlop W, Iqbal I, Khan I, Ouwens M, Heron L
Format: Article
Language:English
Published: Dove Medical Press 2013-10-01
Series:ClinicoEconomics and Outcomes Research
Online Access:http://www.dovepress.com/cost-effectiveness-of-modified-release-prednisone-in-the-treatment-of--a14827

Internet

http://www.dovepress.com/cost-effectiveness-of-modified-release-prednisone-in-the-treatment-of--a14827

Similar Items